16-5025525-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_016256.4(NAGPA):c.1501G>A(p.Ala501Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000313 in 1,613,036 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Consequence
NM_016256.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00161 AC: 245AN: 152254Hom.: 1 Cov.: 34
GnomAD3 exomes AF: 0.000553 AC: 139AN: 251238Hom.: 0 AF XY: 0.000449 AC XY: 61AN XY: 135868
GnomAD4 exome AF: 0.000179 AC: 261AN: 1460664Hom.: 2 Cov.: 30 AF XY: 0.000162 AC XY: 118AN XY: 726626
GnomAD4 genome AF: 0.00160 AC: 244AN: 152372Hom.: 1 Cov.: 34 AF XY: 0.00148 AC XY: 110AN XY: 74518
ClinVar
Submissions by phenotype
NAGPA-related disorder Benign:1
This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at